Camlin Fine Sciences Ltd (CAMLINFINE) — concall transcript | 30 June 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team AI-Assisted Analysis Source: BSE/NSE Filings
📢 Key Event
Camlin Fine Sciences reported Q1 FY27 revenue of INR5,199 million, up 28% YoY, but EBITDA margin collapsed to 4% due to raw material and freight cost pressures, prompting revised FY27 guidance.
🔄 What Changed
EBITDA margin dropped to 4% from prior quarter, raw material and freight costs remain elevated, diphenol plant shutdown reduced internal sales, and working capital needs increased due to Red Sea delays.
🔮 What's Next
FY27 revenue target of INR2,200-2,300 crores, EBITDA margin guidance of 10-12% (INR220-230 crores), and EBITDA quarterly target of INR250-280 crores.
💡 Investor Takeaway
Shareholders should note that while top-line growth is strong, margin pressure from costs and operational disruptions requires near-term execution on capacity and cost pass-through to meet guidance.

Camlin Fine Sciences reported Q1 FY27 revenue of INR5,199 million, up 28% YoY and 100% QoQ, driven by Specialty Ingredients and vanillin sales, but EBITDA margin fell to 4% due to high raw material and freight costs, phenol volatility, and a diphenol plant shutdown. The company revised FY27 revenue guidance to INR2,200-2,300 crores and EBITDA margin to 10-12%, with EBITDA quarterly target of INR250-280 crores. Capacity expansion for ethyl vanillin is underway (350 tons sold), while diphenol production is suspended, relying on Chinese intermediates. An INR400 million insurance claim related to a Brazil fire was settled with a 20% haircut. Working capital needs rose due to Red Sea delays and slower customer recoveries. Management expects margin recovery in Q3 as utilization improves and vanillin margins target 7% at $13/kg.

📄 View Original Announcement (PDF)

About Camlin Fine Sciences Ltd (CAMLINFINE)

Chemicals · Chemicals · Listed on BSE

Market Cap: ₹1,975.71 Cr ROE: 0.1% ROCE: 0.5%

View full CAMLINFINE stock details →

📡 Get AI alerts when CAMLINFINE files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track CAMLINFINE — Free

📊 More CAMLINFINE filings

See all CAMLINFINE filings →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when CAMLINFINE files new disclosures

Track CAMLINFINE filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track CAMLINFINE — Free

Free account · 2 AI queries/day